Humana Denied Your Sleep Study? How to Appeal

Why Humana Denies Sleep Study Claims

Sleep disorders affect tens of millions of Americans, and polysomnography (sleep study) is the gold standard for diagnosing obstructive sleep apnea, central sleep apnea, narcolepsy, periodic limb movement disorder, and other conditions that carry serious cardiovascular and neurological consequences when untreated. Despite the well-documented medical risks of undiagnosed sleep disorders, Humana routinely denies sleep study claims, leaving patients unable to obtain the diagnostic testing their physicians have ordered.

Home sleep test requirement. Humana's clinical policies strongly prefer home sleep apnea testing (HSAT) over in-laboratory polysomnography (PSG) for the initial evaluation of suspected obstructive sleep apnea in adults. If your physician ordered an in-lab sleep study without first attempting a home sleep test, Humana will likely deny the claim. However, in-lab PSG is clinically appropriate when the patient has significant comorbidities (congestive heart failure, chronic opioid use, severe COPD, neuromuscular disease), when home testing is technically inadequate, or when a non-apnea sleep disorder is suspected.

Clinical criteria not met. Humana requires specific clinical criteria to authorize a sleep study. Typically, the patient must have symptoms consistent with a sleep disorder -- excessive daytime sleepiness, witnessed apneas, loud snoring, morning headaches, cognitive impairment -- along with clinical findings that support the diagnosis. If the ordering physician's documentation does not clearly describe these qualifying symptoms, Humana will deny the study.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization not obtained. Humana requires prior authorization for both in-lab and home sleep studies. If the study was performed without prior authorization, Humana will deny the claim regardless of the clinical results.

CPAP and treatment denials. Even after a sleep study confirms sleep apnea, Humana may deny coverage for CPAP equipment or oral appliances. Humana typically requires an apnea-hypopnea index (AHI) of five or greater with documented symptoms, or an AHI of 15 or greater regardless of symptoms, to authorize CPAP therapy. Humana may also impose compliance monitoring requirements, threatening to discontinue CPAP coverage if the patient does not demonstrate adequate usage (typically four or more hours per night for at least 70% of nights) during the initial compliance period.

Split-night study denials. Humana may deny the CPAP titration portion of a split-night study or deny a subsequent full-night CPAP titration study, asserting that auto-titrating CPAP (APAP) eliminates the need for in-lab titration. While APAP is appropriate for many patients, in-lab titration is clinically necessary for patients with complex sleep apnea, central apnea, or significant comorbidities.

Common Denial Codes and Reasons

• Not medically necessary -- Humana's reviewer determined the sleep study is not clinically justified
• Home sleep test not attempted first -- Humana requires HSAT before authorizing in-lab polysomnography
• Clinical criteria not met -- Documentation does not demonstrate qualifying symptoms or risk factors
• Prior authorization not obtained -- The sleep study was performed without required authorization
• AHI threshold not met for CPAP -- The sleep study results do not meet Humana's criteria for CPAP authorization
• CPAP compliance not demonstrated -- The patient did not meet usage requirements during the compliance period
• Titration study not authorized -- Humana asserts auto-titrating CPAP eliminates the need for in-lab titration

Your Legal Rights

ACA Essential Health Benefits

The ACA requires ACA-compliant plans to cover diagnostic services, which includes medically necessary sleep studies. Sleep testing is a covered diagnostic benefit, and Humana cannot categorically exclude it. The ACA also requires coverage of durable medical equipment, which includes CPAP machines and related supplies.

Medicare Coverage Criteria (for Humana Medicare Advantage)

If you have a Humana Medicare Advantage plan, Medicare's national coverage determination for CPAP therapy applies. Medicare covers CPAP for beneficiaries with an AHI of five or greater with documented symptoms, or AHI of 15 or greater. Medicare requires a 90-day compliance period but also provides specific appeal rights through the Medicare appeals process, including Qualified Independent Contractor (QIC) review and Administrative Law Judge hearings.

erisa-protections">ERISA Protections

For employer-sponsored Humana plans, ERISA guarantees your right to appeal, access to the complete claims file, and a written explanation of the denial. ERISA's strict timelines require Humana to respond to pre-service appeals within 30 days and post-service appeals within 60 days.

Clinical Standards from AASM

The American Academy of Sleep Medicine (AASM) publishes clinical guidelines for sleep study indications, CPAP therapy, and follow-up testing. AASM guidelines support in-lab polysomnography (rather than home testing) for patients with significant cardiopulmonary disease, suspected non-apnea sleep disorders, and when home testing is technically inadequate or inconclusive. Citing AASM guidelines in your appeal establishes the clinical standard of care.

Step-by-Step Appeal Instructions

Step 1: Request the Complete Claims File

Contact Humana and request the full claims file, including the specific clinical policy applied (Humana's sleep study medical necessity criteria), the reviewer's credentials and notes, and the specific criteria the reviewer found were not met.

Step 2: Obtain Supporting Documentation from Your Physician

Your ordering physician (typically a sleep medicine specialist, pulmonologist, or neurologist) should provide:

• Complete sleep history including symptoms: excessive daytime sleepiness (quantified with Epworth Sleepiness Scale score), witnessed apneas, gasping or choking during sleep, loud snoring, morning headaches, nocturia, cognitive impairment
• Physical examination findings: BMI, neck circumference, Mallampati score, oropharyngeal examination
• Comorbid conditions that increase the medical urgency of diagnosis: hypertension, atrial fibrillation, heart failure, type 2 diabetes, history of stroke, commercial driving or safety-sensitive occupation
• If in-lab PSG was ordered instead of HSAT: specific clinical reasons (comorbidities, suspected non-apnea disorder, prior failed HSAT, need for supplemental oxygen titration)
• If CPAP was denied: the AHI, oxygen desaturation index, and symptom documentation that meet the clinical threshold
• Citations to AASM clinical guidelines supporting the specific study type ordered
• Cardiovascular and safety risks of leaving the suspected sleep disorder undiagnosed

Step 3: File the Internal Appeal

Submit your appeal within the timeframe specified in the denial letter. Address the specific denial reason:

• If denied for home test first: Explain the clinical reasons in-lab PSG was appropriate as the initial study. Cite AASM guidelines that support in-lab testing for patients with significant comorbidities or suspected non-apnea disorders
• If denied for clinical criteria: Provide detailed symptom documentation with validated assessment tools (Epworth Sleepiness Scale, STOP-BANG score) and clinical findings
• If CPAP denied for AHI threshold: Present the complete sleep study data including the respiratory disturbance index, oxygen desaturation events, and symptom correlation

Request an expedited appeal if the patient is a commercial driver, operates heavy machinery, or has cardiovascular conditions that make delayed diagnosis dangerous.

Step 4: Request a Peer-to-Peer Review

Your sleep medicine physician can request a peer-to-peer review with Humana's medical director to discuss the clinical reasoning for the ordered study and why the specific study type is appropriate for the patient's clinical situation.

Step 5: Pursue External Independent Review: Complete Guide" class="auto-link">External Review

If Humana upholds the denial, file for external review. An independent sleep medicine physician will evaluate the clinical necessity. External review is free and binding on Humana. For Humana Medicare Advantage members, the Medicare appeal process (QIC review) is the equivalent step.

Step 6: File Regulatory Complaints

File a complaint with your state Department of Insurance through the NAIC directory. For Medicare Advantage members, file a complaint with the Centers for Medicare and Medicaid Services (CMS) at 1-800-MEDICARE.

Common Mistakes to Avoid

Not completing a home sleep test when one is feasible. If you are a straightforward sleep apnea suspect without significant comorbidities, completing the home sleep test first is often the fastest path to diagnosis and treatment. Challenge the HSAT-first requirement only when there are legitimate clinical reasons for in-lab testing.

Not using validated screening tools. Including an Epworth Sleepiness Scale score and STOP-BANG score in the clinical documentation quantifies the sleep disorder risk and strengthens the medical necessity argument.

Not documenting comorbidities. The cardiovascular and metabolic consequences of untreated sleep apnea are well-established. Document all comorbidities that make timely diagnosis and treatment urgent.

Ignoring CPAP compliance requirements. If Humana authorizes CPAP with a compliance period, ensure you understand and meet the usage requirements. Track your CPAP usage data and address compliance issues early with your sleep medicine physician.

Not appealing a CPAP denial after the sleep study. Some patients successfully appeal the sleep study denial but then fail to separately appeal a subsequent CPAP denial. Each denial requires its own appeal.

Draft Your Humana Sleep Study Appeal with ClaimBack

Fighting a sleep study denial requires matching your clinical presentation to Humana's specific medical necessity criteria, citing AASM guidelines, and documenting the health risks of delayed diagnosis. ClaimBack at claimback.app generates professional appeal letters tailored to your specific Humana sleep study denial, incorporating the clinical documentation, screening scores, and regulatory arguments that give you the best chance of getting your sleep study approved.

Conclusion

A Humana sleep study denial does not have to leave a potentially serious sleep disorder undiagnosed. With strong clinical documentation, validated screening scores, AASM guideline citations, and a systematic appeal strategy, sleep study denials are frequently overturned. Use internal appeal, peer-to-peer review, external review, and regulatory complaints to fight for the diagnostic testing you need. Start your appeal today with ClaimBack at claimback.app.

Related Reading

• Cigna Denied Your Sleep Study? How to Appeal
• Insurance Denied Sleep Study or CPAP? How to Appeal
• Sleep Study Insurance Claim Denied? How to Appeal
• Humana Denied Cancer Treatment: Your Appeal Rights
• Humana Denied Your Cancer Treatment? How to Appeal